Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1169)	6/30/2005 12:25:02 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

CGPI Is trying to test its January Hs.<g> The stock has continued the uptrend that started on Monday and has already closed the downgap of January 20 It is up more than 10% for the day.The volume has increased significantly this week on the stock's up-move bigcharts.marketwatch.com On a close above its Jan-Dec Hs it seems it could get to the $9-$10 level.<g> bigcharts.marketwatch.com As previously mentioned, CGPI has no no significant LTD and about $2.50 in cash/share. The stock has had a good move from its $3.76 loew last month.<g> Message 21457479 Bernard

To: Jibacoa who wrote (1169)	7/11/2005 11:33:49 AM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

ABRX Opened with another downgap today and is trying to find support at the $1.72 level.The volume is now over 4M and the stock is down 40%.<g> After it received a list from the FDA concerning its products recall, it said that it is evaluating several "strategic options," including a possible bankruptcy filing. bigcharts.marketwatch.com The BV reportedly was around $5.<g> In March some institutions had a few millions invested in ABRX, including T.Rowe Price with 1,465,600 shares; Wellington Management 988,000 shrs; Schroder Investment 956,900 shrs; Lazard 955,513 shrs <g> It seems it merits to keep a close watch to see if it can close some of the recent gap.<g> I doubt it will bounce back to its BV level in the near future. Bernard